PHARMACOKINETICS AND SAFETY OF A LONG-ACTING SUBCUTANEOUS FORMULATION OF 2-METHOXYESTRADIOL (2ME) IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Tofovic, S. [1 ]
Jackson, E. [2 ,3 ]
Piche, C. [4 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Med, Ctr Clin Pharmacol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Med & Pharmacol, Ctr Clin Pharmacol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Biol Chem, Ctr Clin Pharmacol, Pittsburgh, PA USA
[4] PR Pharmaceut, Ft Collins, CO USA
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects
    Agersnap, Mikkel Askjaer
    Sonne, Kim
    Knudsen, Kim Mark
    Knudsen, Carsten Boye
    Berner-Hansen, Mark
    CLINICAL DRUG INVESTIGATION, 2022, 42 (12) : 1093 - 1100
  • [42] Pharmacokinetics, D2 receptor occupancy, and clinical effects of a long-acting injectable formulation of risperidone in patients with schizophrenia
    Gefvert, O
    Nyberg, S
    Persson, P
    Helldin, L
    Björner, A
    Eerdekens, M
    Vermeulen, A
    Woestenborghs, R
    Van Peer, A
    Eriksson, B
    NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 90 - 90
  • [43] Pharmacokinetics, D2 receptor occupancy, and clinical effects of a long-acting injectable formulation of risperidone in patients with schizophrenia
    Gefvert, O
    Nyberg, S
    Persson, P
    Helldin, L
    Björner, A
    Eerdekens, M
    Varmeulen, A
    Woestenborghs, R
    Van Peer, A
    Eriksson, B
    Mannaert, E
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 117S - 117S
  • [44] Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV
    Benaboud, Sihem
    Solas, Caroline
    Bouchet, Stephane
    Gregoire, Matthieu
    Lemaitre, Florian
    Venisse, Nicolas
    Patrick, Minh
    Muret, Patrice
    Parant, Francois
    Neant, Nadege
    Boujafaar, Sana
    Lagoutte-Renosi, Jennifer
    Garraffo, Rodolphe
    Peytavin, Gilles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (03) : 853 - 854
  • [45] Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment
    Mikkel Askjær Agersnap
    Kim Sonne
    Kim Mark Knudsen
    Wladyslaw Sulowicz
    Clinical Pharmacokinetics, 2023, 62 : 653 - 654
  • [46] Long-acting β2-agonist bronchodilators safety for asthma treatment
    Giubergia, Veronica
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2009, 107 (04): : 291 - 293
  • [47] Safety updates for long-acting β2 agonists requested by US FDA
    Reactions Weekly, 2005, 1079 (1) : 2 - 2
  • [48] Safety of long-acting β2-agonists: a little bit of history
    Jaeschke, Roman
    O'Byrne, Paul
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (11): : 910 - 911
  • [49] A Safety Review of Long-Acting beta(2)-Agonists in Patients With Asthma
    Rider, Nicholas L.
    Craig, Timothy J.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2006, 106 (09): : 562 - 567
  • [50] LONG-ACTING beta(2)-AGONISTS: SAFETY CONCERNS AND CAREFUL BALANCE
    Kashyap, Surender
    Mohapatra, Prasanta Raghab
    LUNG INDIA, 2006, 23 (03) : 97 - 99
12345